136 related articles for article (PubMed ID: 946965)
1. Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.
Mazurek C; Chalvet H; Stiffel CL; Biozzi G
Int J Cancer; 1976 Apr; 17(4):511-7. PubMed ID: 946965
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effect of Corynebacterium parvum].
Mazurek C; Chalvet H; Biozzi G; Stiffel C
Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
[TBL] [Abstract][Full Text] [Related]
3. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
Stiffel C; Chalvet H; Mazurek C
Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
[TBL] [Abstract][Full Text] [Related]
4. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
Mazurek C; Stiffel C; Chalvet H; Biozzi G
Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
[TBL] [Abstract][Full Text] [Related]
5. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
Mazurek C; Stiffel C; Chalvet H; Biozzi G
Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
[TBL] [Abstract][Full Text] [Related]
6. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
Thomson AW; Cruickshank N; Fowler EF
Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
[No Abstract] [Full Text] [Related]
7. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
Mazureka C; Stiffel C; Chalvet H; Biozzi G
C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
Mazurek C; Chalvet H; Stiffel C; Biozzi G
Int J Cancer; 1977 Oct; 20(4):532-4. PubMed ID: 334678
[TBL] [Abstract][Full Text] [Related]
9. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
[TBL] [Abstract][Full Text] [Related]
11. C. parvum treatment of transplanted rat tumours of spontaneous origin.
Willmott N; Pimm MV; Baldwin RW
Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
[TBL] [Abstract][Full Text] [Related]
12. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
Woodruff MF; Whitehead VL; Speedy G
Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
[TBL] [Abstract][Full Text] [Related]
13. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.
Woodruff MF; Inchley MP; Dunbar N
Br J Cancer; 1972 Apr; 26(2):67-76. PubMed ID: 5038327
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
Suit HD; Sedlacek RS; Silobrcic V; Linggood RM
Cancer; 1976 Jun; 37(6):2573-9. PubMed ID: 949676
[TBL] [Abstract][Full Text] [Related]
15. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
Motycka K; Chudomel V; Bednár M; Bostík J
Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
[TBL] [Abstract][Full Text] [Related]
16. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
Motycka K; Chudomel V; Bednár M; Bostík J
Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
[TBL] [Abstract][Full Text] [Related]
17. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
Fisher B; Wolmark N; Rubin H
J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
[TBL] [Abstract][Full Text] [Related]
18. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
19. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
20. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]